Woodline Partners’s MoonLake Immunotherapeutics MLTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.7M | Buy |
310,602
+14,454
| +5% | +$682K | 0.08% | 353 |
|
|
2025
Q1 | $11.6M | Buy |
296,148
+2,613
| +0.9% | +$102K | 0.08% | 332 |
|
|
2024
Q4 | $15.9M | Buy |
293,535
+61,105
| +26% | +$3.31M | 0.11% | 250 |
|
|
2024
Q3 | $11.7M | Buy |
232,430
+5,713
| +3% | +$288K | 0.1% | 269 |
|
|
2024
Q2 | $9.97M | Buy |
226,717
+19,302
| +9% | +$849K | 0.1% | 245 |
|
|
2024
Q1 | $10.4M | Buy |
207,415
+85,661
| +70% | +$4.3M | 0.1% | 262 |
|
|
2023
Q4 | $7.35M | Buy |
121,754
+20,005
| +20% | +$1.21M | 0.08% | 262 |
|
|
2023
Q3 | $5.8M | Buy |
101,749
+52,270
| +106% | +$2.98M | 0.07% | 299 |
|
|
2023
Q2 | $2.52M | Buy |
+49,479
| New | +$2.52M | 0.03% | 396 |
|